STAAR Surgical Valuation
| STAA Stock | USD 18.25 0.03 0.16% |
At this time, the company appears to be undervalued. STAAR Surgical owns a latest Real Value of $23.4 per share. The recent price of the company is $18.25. Our model measures the value of STAAR Surgical from inspecting the company fundamentals such as current valuation of 709.92 M, and Return On Equity of -0.0516 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting STAAR Surgical's valuation include:
Undervalued
Today
Please note that STAAR Surgical's price fluctuation is not too volatile at this time. Calculation of the real value of STAAR Surgical is based on 3 months time horizon. Increasing STAAR Surgical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since STAAR Surgical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of STAAR Stock. However, STAAR Surgical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.25 | Real 23.4 | Target 40.98 | Hype 18.26 | Naive 18.37 |
The real value of STAAR Stock, also known as its intrinsic value, is the underlying worth of STAAR Surgical Company, which is reflected in its stock price. It is based on STAAR Surgical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of STAAR Surgical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of STAAR Surgical helps investors to forecast how STAAR stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of STAAR Surgical more accurately as focusing exclusively on STAAR Surgical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use STAAR Surgical's intrinsic value based on its ongoing forecasts of STAAR Surgical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against STAAR Surgical's closest peers. If more than one evaluation category is relevant for STAAR Surgical we suggest using both methods to arrive at a better estimate.
STAAR Surgical Cash |
|
STAAR Valuation Trend
Comparing STAAR Surgical's enterprise value against its market capitalization is a good way to estimate the value of STAAR Surgical uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
STAAR Revenue by Product
STAAR Surgical Total Value Analysis
STAAR Surgical is at this time forecasted to have valuation of 709.92 M with market capitalization of 901.67 M, debt of 38.74 M, and cash on hands of 202.49 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the STAAR Surgical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
709.92 M | 901.67 M | 38.74 M | 202.49 M |
STAAR Surgical Investor Information
About 100.0% of the company shares are owned by institutional investors. The book value of STAAR Surgical was at this time reported as 8.06. The company has Price/Earnings (P/E) ratio of 460.83. STAAR Surgical recorded a loss per share of 0.41. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 18th of May 1992. STAAR Surgical is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.STAAR Surgical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. STAAR Surgical has an asset utilization ratio of 61.61 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that STAAR Surgical is more efficient with each dollar of assets it utilizes for everyday operations.STAAR Surgical Ownership Allocation
STAAR Surgical secures a total of 49.33 Million outstanding shares. The majority of STAAR Surgical outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in STAAR Surgical to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in STAAR Surgical. Please pay attention to any change in the institutional holdings of STAAR Surgical as this could imply that something significant has changed or is about to change at the company. Also note that nearly twenty-four thousand six hundred sixty-three invesors are currently shorting STAAR Surgical expressing very little confidence in its future performance.STAAR Surgical Profitability Analysis
The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 239.58 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates STAAR Surgical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in STAAR Surgical and how it compares across the competition.
About STAAR Surgical Valuation
The stock valuation mechanism determines STAAR Surgical's current worth on a weekly basis. Our valuation model uses a comparative analysis of STAAR Surgical. We calculate exposure to STAAR Surgical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of STAAR Surgical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 239.6 M | 251.6 M | |
| Pretax Profit Margin | 0.14 | 0.14 | |
| Operating Profit Margin | 0.14 | 0.15 | |
| Net Profit Margin | 0.12 | 0.13 | |
| Gross Profit Margin | 0.78 | 0.49 |
STAAR Surgical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.1 M | |
| Quarterly Earnings Growth Y O Y | 1.018 | |
| Forward Price Earnings | 625 |
STAAR Surgical Current Valuation Indicators
Valuation refers to the process of determining the present value of STAAR Surgical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value STAAR we look at many different elements of the entity such as STAAR's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as STAAR Surgical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use STAAR Surgical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes STAAR Surgical's worth.Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |